A citation-based method for searching scientific literature

Xiaozhu Liu, Song Yue, Haodong Huang, Minjie Duan, Binyi Zhao, Jin Liu, Tianyu Xiang. Front Med (Lausanne) 2021
Times Cited: 3







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cancer statistics, 2022.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2022
66

Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
66

Development and validation of a nomogram for osteosarcoma-specific survival: A population-based study.
Jun Zhang, Jin Yang, Hai-Qiang Wang, Zhenyu Pan, Xiaoni Yan, Chuanyu Hu, Yuanjie Li, Jun Lyu. Medicine (Baltimore) 2019
14
33

Limb salvage versus amputation in patients with osteosarcoma of the extremities: an update in the modern era using the National Cancer Database.
Daniel R Evans, Alexander L Lazarides, Julia D Visgauss, Jason A Somarelli, Dan G Blazer, Brian E Brigman, William C Eward. BMC Cancer 2020
26
33

The art of limb salvage in musculoskeletal oncology.
R P Veth, Q G van Hoesel, J P Bökkerink, J Hoogenhout, M Pruszczynski. Crit Rev Oncol Hematol 1995
20
33

A predictive model with a risk-classification system for cancer-specific survival in patients with primary osteosarcoma of long bone.
Shuo Tian, Sheng Liu, Xiangcheng Qing, Hui Lin, Yizhong Peng, Baichuan Wang, Zengwu Shao. Transl Oncol 2022
1
100

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors.
D G Altman, B Lausen, W Sauerbrei, M Schumacher. J Natl Cancer Inst 1994
852
33


Osteosarcoma.
J Ritter, S S Bielack. Ann Oncol 2010
497
33

A propensity-score matched analysis of limb salvage vs amputation for osteosarcoma.
Sophia A Traven, Daniel L Brinton, Zeke J Walton, Lee R Leddy. J Surg Oncol 2019
12
33


Predictors and Survival of Patients with Osteosarcoma After Limb Salvage versus Amputation: A Population-Based Analysis with Propensity Score Matching.
Lin Qi, Xiaolei Ren, Zhongyue Liu, Shuangqing Li, Wenchao Zhang, Ruiqi Chen, Congzhou Chen, Chao Tu, Zhihong Li. World J Surg 2020
15
33

Advances in limb salvage treatment of osteosarcoma.
Yichun Yang, Lei Han, Zewei He, Xiaojuan Li, Suping Yang, Jifei Yang, Ya Zhang, Dongqi Li, Yihaho Yang, Zuozhang Yang. J Bone Oncol 2017
56
33

Surgical Advances in Osteosarcoma.
Marcus J Brookes, Corey D Chan, Bence Baljer, Sachin Wimalagunaratna, Timothy P Crowley, Maniram Ragbir, Alistair Irwin, Zakareya Gamie, Thomas Beckingsale, Kanishka M Ghosh,[...]. Cancers (Basel) 2021
13
33

Nomograms in oncology: more than meets the eye.
Vinod P Balachandran, Mithat Gonen, J Joshua Smith, Ronald P DeMatteo. Lancet Oncol 2015
33

Development and Validation of the Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Patients With Synovial Sarcoma.
Zhengqing Song, Lisha Cheng, Lili Lu, Weiqi Lu, Yuhong Zhou, Zhiming Wang. Front Endocrinol (Lausanne) 2022
1
100

Development and validation of a nomogram for predicting survival in patients with surgically resected lung invasive mucinous adenocarcinoma.
Guochao Zhang, Xuefei Wang, Jia Jia, Zhichao Zuo, Lide Wang, Shugeng Gao, Liyan Xue, Qi Xue. Transl Lung Cancer Res 2021
4
33

Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
C Marth, F Landoni, S Mahner, M McCormack, A Gonzalez-Martin, N Colombo. Ann Oncol 2018
40
33

Amputation Predisposes to Higher Cancer-Specific Mortality Than Limb Salvage Surgery in Pediatric Patients With Osteosarcoma of the Limbs: A Propensity Matching Analysis.
Jinkui Wang, Jie Tang, Xiaojun Tan, Chenghao Zhanghuang, Liming Jin, Mujie Li, Zhaoxia Zhang, Tao Mi, Dawei He. Front Surg 2022
1
100





A Novel Nomogram Based on Log Odds of Metastatic Lymph Nodes to Predict Overall Survival in Patients With Perihilar Cholangiocarcinoma After Surgery.
Wenbo Zou, Chunyu Zhu, Zizheng Wang, Xianglong Tan, Chenggang Li, Zhiming Zhao, Minggen Hu, Rong Liu. Front Oncol 2021
1
100




A comparative study between limb-salvage and amputation for treating osteosarcoma.
Xiaojuan Li, Ya Zhang, Shanshan Wan, Huiling Li, Dongqi Li, Junfeng Xia, Zhongqin Yuan, Mingyan Ren, Shunling Yu, Su Li,[...]. J Bone Oncol 2016
41
33

Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma.
P Picci, L Sangiorgi, B T Rougraff, J R Neff, R Casadei, M Campanacci. J Clin Oncol 1994
198
33

Current approaches to management of bone sarcoma in adolescent and young adult patients.
Katrina M Ingley, Alessandra Maleddu, Franel Le Grange, Craig Gerrand, Archie Bleyer, Ephia Yasmin, Jeremy Whelan, Sandra J Strauss. Pediatr Blood Cancer 2022
4
33

Nomogram application to predict overall and cancer-specific survival in osteosarcoma.
Weipeng Zheng, Yuanping Huang, Haoyi Chen, Ning Wang, Wende Xiao, YingJie Liang, Xin Jiang, Wenzhou Su, Shifeng Wen. Cancer Manag Res 2018
33
33

How to build and interpret a nomogram for cancer prognosis.
Alexia Iasonos, Deborah Schrag, Ganesh V Raj, Katherine S Panageas. J Clin Oncol 2008
33

Prediction Models for Public Health Containment Measures on COVID-19 Using Artificial Intelligence and Machine Learning: A Systematic Review.
Anil Babu Payedimarri, Diego Concina, Luigi Portinale, Massimo Canonico, Deborah Seys, Kris Vanhaecht, Massimiliano Panella. Int J Environ Res Public Health 2021
8
33

Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database.
Benjamin J Miller, Peter Cram, Charles F Lynch, Joseph A Buckwalter. J Bone Joint Surg Am 2013
112
33

Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.
Stefan S Bielack, Beate Kempf-Bielack, Günter Delling, G Ulrich Exner, Silke Flege, Knut Helmke, Rainer Kotz, Mechthild Salzer-Kuntschik, Matthias Werner, Winfried Winkelmann,[...]. J Clin Oncol 2002
33

Incidence and survival of malignant bone sarcomas in England 1979-2007.
Jeremy Whelan, Anne McTiernan, Nicola Cooper, Yuen K Wong, Matthew Francis, Sally Vernon, Sandra J Strauss. Int J Cancer 2012
146
33

Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
P G Casali, S Bielack, N Abecassis, H T Aro, S Bauer, R Biagini, S Bonvalot, I Boukovinas, J V M G Bovee, B Brennan,[...]. Ann Oncol 2018
190
33

Decision curve analysis: a novel method for evaluating prediction models.
Andrew J Vickers, Elena B Elkin. Med Decis Making 2006
33

X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.
Robert L Camp, Marisa Dolled-Filhart, David L Rimm. Clin Cancer Res 2004
33


Risk Factors, Prognostic Factors, and Nomograms for Distant Metastasis in Patients With Newly Diagnosed Osteosarcoma: A Population-Based Study.
Bo Chen, Yuan Zeng, Bo Liu, Gaoxiang Lu, Zhouxia Xiang, Jiyang Chen, Yan Yu, Ziyi Zuo, Yangjun Lin, Jinfeng Ma. Front Endocrinol (Lausanne) 2021
15
33

Limb salvage in musculoskeletal oncology.
René Veth, René van Hoesel, Maciej Pruszczynski, Jaap Hoogenhout, Bart Schreuder, Theo Wobbes. Lancet Oncol 2003
43
33

Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance.
Min Xia, Xuyu Zu, Zuyao Chen, Gebo Wen, Jing Zhong. Cancer Lett 2021
5
33

Applications of CRISPR-Cas in agriculture and plant biotechnology.
Haocheng Zhu, Chao Li, Caixia Gao. Nat Rev Mol Cell Biol 2020
168
33

Multifunctional biomolecule nanostructures for cancer therapy.
Jing Wang, Yiye Li, Guangjun Nie. Nat Rev Mater 2021
58
33

RNA virus interference via CRISPR/Cas13a system in plants.
Rashid Aman, Zahir Ali, Haroon Butt, Ahmed Mahas, Fatimah Aljedaani, Muhammad Zuhaib Khan, Shouwei Ding, Magdy Mahfouz. Genome Biol 2018
233
33

The Chk2-PKM2 axis promotes metabolic control of vasculogenic mimicry formation in p53-mutated triple-negative breast cancer.
Pei Yu, Xiong Zhu, Jia-Le Zhu, Yu-Bao Han, Hao Zhang, Xiang Zhou, Lei Yang, Yuan-Zheng Xia, Chao Zhang, Ling-Yi Kong. Oncogene 2021
4
33

ELP-dependent expression of MCL1 promotes resistance to EGFR inhibition in triple-negative breast cancer cells.
Peter Cruz-Gordillo, Megan E Honeywell, Nicholas W Harper, Thomas Leete, Michael J Lee. Sci Signal 2020
7
33

LncRNA-HAGLR motivates triple negative breast cancer progression by regulation of WNT2 via sponging miR-335-3p.
Liting Jin, Chenggang Luo, Xinhong Wu, Manxiu Li, Shun Wu, Yaojun Feng. Aging (Albany NY) 2021
3
33

Noninvasively immunogenic sonodynamic therapy with manganese protoporphyrin liposomes against triple-negative breast cancer.
Huaqing Chen, Lanlan Liu, Aiqing Ma, Ting Yin, Ze Chen, Ruijing Liang, Yuzhi Qiu, Mingbin Zheng, Lintao Cai. Biomaterials 2021
32
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.